The aim of this study is to demonstrate that the use of the Pure-Vu EVS System can salvage inadequately prepared optical colonoscopies (OCs) to adequate OCs.
The primary objective of this study is to demonstrate the reduction of inadequate colonoscopies when Pure-Vu EVS System is used to salvage inadequately prepped colons as defined by the multi-society guidelines (USMSTF).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
16
Subjects will be enrolled until 115 inadequate bowel prep cases via SOC are accrued and subsequently treated with Pure-Vu EVS. Inadequate OCs defined as such if any of the following are met: * Boston Bowel Preparation Score (BBPS) \< 6 (Adequacy is defined as BBPS of 2 or greater in each segment) * Inability to identify \> 5mm polyps
NYU
New York, New York, United States
Rate of incomplete colonoscopies
Rate of incomplete colonoscopies due to inadequate preparation salvaged to adequate colonoscopies with the use of the Pure-Vu EVS System. Inadequate OCs defined as such if any of the following are met: * BBPS \< 6 (Adequacy is defined as BBPS of 2 or greater in each segment) * Inability to identify \> 5mm polyps The estimated rate of salvaged preparations will be calculated and presented with exact one-sided 95% confidence interval: Number of preps inadequate with SOC and adequate after Pure-VU EVS System / Number of preps inadequate with SOC. The lower bound will be compared to a 35% performance goal.
Time frame: Day 0 (Procedure Day)
Assessment of Screening
The following secondary endpoint will be assessed: Number of polyps and adenomas: type, location, size, pathology and morphology
Time frame: Day 0 (Procedure Day)
Assessment of Screening
Boston Bowel Prep Score (BBPS) before and after Pure-Vu EVS use. Throughout the procedure, the study endoscopist will be requested to document the pre-cleansing BBPS and post- cleansing BBPS for each colon segment.
Time frame: Day 0 (Procedure Day)
Procedural Outcome
Sedation type The type of sedation will not be dictated by the study but will be documented.
Time frame: Day 0 (Procedure Day)
Procedural Outcome
Cecum Intubation Rate
Time frame: Day 0 (Procedure Day)
Assessment screening
Polyp Miss Rate (PMR)
Time frame: Day 0 (Procedure Day)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Assessment screening
Adenoma Detection Rate (ADR)
Time frame: Day 0 (Procedure Day)
Assessment screening
Adenoma Miss Rate (AMR)
Time frame: Day 0 (Procedure Day)
Assessment screening
Adenoma Per Colonoscopy (APC)
Time frame: Day 0 (Procedure Day)
Assessment screening
Adenomas Per Positive Patient (APP)
Time frame: Day 0 (Procedure Day)
Assessment screening
Sessile Serrated Adenoma Detection Rate
Time frame: Day 0 (Procedure Day)
Assessment Screening
Polyp Detection Rate (PDR)
Time frame: Day 0 (Procedure Day)
Procedural Outcomes
Procedure Time: Time to cecum and withdrawal time
Time frame: Day 0 (Procedure Day)
Procedural Outcomes
Intraprocedural tools The type of Intraprocedural tools will not be dictated by the study but will be documented.
Time frame: Day 0 (Procedure Day)